Influenza serological studies to inform public health action: best practices to optimise timing, quality and reporting.
about
Weighing serological evidence of human exposure to animal influenza viruses - a literature reviewEstimating age-specific cumulative incidence for the 2009 influenza pandemic: a meta-analysis of A(H1N1)pdm09 serological studies from 19 countries.Factors influencing infection by pandemic influenza A(H1N1)pdm09 over three epidemic waves in Singapore.Seroprevalence of antibody to influenza A(H1N1)pdm09 attributed to vaccination or infection, before and after the second (2010) pandemic wave in Australia.IgM, IgG, and IgA antibody responses to influenza A(H1N1)pdm09 hemagglutinin in infected persons during the first wave of the 2009 pandemic in the United StatesChanges in heterosubtypic antibody responses during the first year of the 2009 A(H1N1) influenza pandemicThe consortium for the standardization of influenza seroepidemiology (CONSISE): a global partnership to standardize influenza seroepidemiology and develop influenza investigation protocols to inform public health policy.International Laboratory Comparison of Influenza Microneutralization Assays for A(H1N1)pdm09, A(H3N2), and A(H5N1) Influenza Viruses by CONSISEInfluenza, influenza-like symptoms and their association with cardiovascular risks: a systematic review and meta-analysis of observational studies.Lessons from Ebola: Improving infectious disease surveillance to inform outbreak management.Novel multiplex assay platforms to detect influenza A hemagglutinin subtype-specific antibody responses for high-throughput and in-field applications.Strategies Using Bio-Layer Interferometry Biosensor Technology for Vaccine Research and Development.
P2860
Q28075317-31747121-7943-402A-820C-5687C7021F95Q30223476-74FA7E89-BB46-43A0-9E11-5B7DCE5FA461Q30351890-2F5655B4-0AB2-4F79-B5DE-F6E320BED71FQ30357438-41035663-604D-4EA5-8A89-94562DA876FCQ30362980-18BF7E88-BDB6-484C-BA03-B2C639A26B16Q30384225-90CAC94A-E481-4C00-9D40-81D46BFBAB58Q30425378-B17FDC45-1621-4928-8941-B93FE36F589EQ35901999-E34CE869-D366-4AB5-A513-1E18011A76FBQ38458413-62A05231-9B7D-4F32-9C74-6991DBC9CC64Q38596317-4908F92C-76E0-4E41-82E7-BBD03A2578DAQ40329744-2B985673-A9D2-4E1F-9DAA-9A376E5D245AQ47171892-A68ACECA-F473-445E-9ED8-2AAB675D3F68
P2860
Influenza serological studies to inform public health action: best practices to optimise timing, quality and reporting.
description
2013 nî lūn-bûn
@nan
2013 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի մարտին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
name
Influenza serological studies ...... timing, quality and reporting.
@ast
Influenza serological studies ...... timing, quality and reporting.
@en
type
label
Influenza serological studies ...... timing, quality and reporting.
@ast
Influenza serological studies ...... timing, quality and reporting.
@en
prefLabel
Influenza serological studies ...... timing, quality and reporting.
@ast
Influenza serological studies ...... timing, quality and reporting.
@en
P2093
P2860
P50
P921
P1476
Influenza serological studies ...... timing, quality and reporting
@en
P2093
Angus Nicoll
Donald J Willison
Eeva Broberg
Elizabeth Miller
John S Tam
Kaat Vandemaele
Katja Hoschler
Patricia Huston
P2860
P304
P356
10.1111/J.1750-2659.2012.0370A.X
P577
2012-04-30T00:00:00Z